487 filings
Page 6 of 25
UPLOAD
aofki
22 Dec 22
Letter from SEC
12:00am
CORRESP
e2s2o8kc4h23htvj
22 Dec 22
Correspondence with SEC
12:00am
6-K
00n3r2ohop6
19 Dec 22
Altamira Therapeutics Provides Year-End 2022 Business Update
4:31pm
F-1
ucvx17
16 Dec 22
Registration statement (foreign)
4:31pm
6-K
amblfpnke09 l7u9egg
5 Dec 22
Report of Foreign Private Issuer
4:30pm
6-K
g1rbdb79u
30 Nov 22
Report of Foreign Private Issuer
9:00am
6-K
w16r2ip1aclr4m11w
9 Nov 22
Report of Foreign Private Issuer
9:00am
6-K
fekv49
24 Oct 22
Share Purchase Agreement
4:30pm
6-K
zymzslc rgk1esmvmwr
24 Oct 22
Report of Foreign Private Issuer
9:00am
EFFECT
2e4qcfn0xc gd83gnij
3 Oct 22
Notice of effectiveness
12:15am
6-K
tyql6zp
29 Sep 22
Report of Foreign Private Issuer
4:30pm
CORRESP
74wyodfpfo02szbjyg4n
29 Sep 22
Correspondence with SEC
12:00am
UPLOAD
qtx5maw9ltv5m5t3av
29 Sep 22
Letter from SEC
12:00am
F-3
bl0nd
23 Sep 22
Shelf registration (foreign)
4:30pm
SC 13D/A
ctlsakqd0o6ryydta8w
13 Sep 22
Altamira Therapeutics / Meyer Thomas ownership change
8:00am
6-K
pgak6
12 Sep 22
Report of Foreign Private Issuer
4:22pm
6-K
v1g ffla2uqt9
30 Aug 22
Altamira Therapeutics Provides Business Update
4:30pm
6-K
20nvgm6646st7j4qe
26 Aug 22
Notice of the Special General Meeting of Shareholders
4:30pm
6-K
fjg23pbp zn
27 Jun 22
Altamira Therapeutics Receives FDA 510(k) Clearance
8:31am
6-K
xi86mcn
13 Jun 22
Altamira Therapeutics Announces Top-Line Data from AM-125 Phase 2 Study in Acute Vertigo
9:30am